Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Revenue (2023 - 2024)

Fractyl Health (GUTS) has disclosed Revenue for 2 consecutive years, with $3000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Revenue fell 57.14% year-over-year to $3000.0, compared with a TTM value of $3000.0 through Sep 2025, down 96.91%, and an annual FY2024 reading of $93000.0, down 22.5% over the prior year.
  • Revenue was $3000.0 for Q4 2024 at Fractyl Health, down from $14000.0 in the prior quarter.
  • Across five years, Revenue topped out at $72000.0 in Q2 2023 and bottomed at $3000.0 in Q4 2024.